
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study
Author(s) -
Matteo Megna,
Luigi Fornaro,
Luca Potestio,
Maria Antonietta Luciano,
Mariateresa Nocerino,
Mario Delfino,
Maria Guarino,
Gabriella Fabbrocini,
Elisa Camela
Publication year - 2022
Publication title -
psoriasis
Language(s) - English
Resource type - Journals
ISSN - 2230-326X
DOI - 10.2147/ptt.s365493
Subject(s) - biosimilar , medicine , etanercept , psoriasis , adalimumab , psoriatic arthritis , adverse effect , psoriasis area and severity index , infliximab , observational study , dermatology , tumor necrosis factor alpha